Cerebral Palsy

Seminars in Perinatology

Volumn 32, Issue 1, 2008, Pages 35-41

  O'Shea, Michael ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral palsy; developmental impairment; extreme prematurity; neuromotor impairment; spasticity

Indexed keywords

GLUCOCORTICOID; INDOMETACIN; MAGNESIUM SULFATE;

ATAXIA; ATHETOSIS; BRAIN HEMORRHAGE; CEREBRAL PALSY; CLINICAL TRIAL; COMORBIDITY; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; DYSTONIA; HUMAN; LIFE EXPECTANCY; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PERINATAL CARE; PHOTOTHERAPY; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SPASTICITY; WELLBEING;

CEREBRAL PALSY; DEVELOPMENTAL DISABILITIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT;

EID: 38649108856     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2007.12.008     Document Type: Review

References (90)

1. Washburn L.K., Dillard R.G., Goldstein D.J., et al. Survival and major neurodevelopmental impairment in extremely low gestational age newborns born 1990-2000: a retrospective cohort study. BMC Pediatr 7 (2007) 20
2. Doyle L.W. Outcome to five years of age of children born at 24-26 weeks' gestational age in Victoria. The Victorian Infant Collaborative Study Group. Med J Aust 163 (1995) 11-14
3. Wood N.S., Marlow N., Costeloe K., et al. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 343 (2000) 378-384
4. Winter S., Autry A., Boyle C., et al. Trends in the prevalence of cerebral palsy in a population-based study. Pediatrics 110 (2002) 1220-1225
5. Drummond P.M., and Colver A.F. Analysis by gestational age of cerebral palsy in singleton births in north-east England 1970-94. Paediatr Perinat Epidemiol 16 (2002) 172-180
6. Ellenberg J.H., and Nelson K.B. Early recognition of infants at high risk for cerebral palsy: examination at age four months. Dev Med Child Neurol 23 (1981) 705-716
7. Rosenbaum P. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 49 (2007) 480
8. Palisano R., Rosenbaum P., Walter S., et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 39 (1997) 214-223
9. Blair E., and Watson L. Epidemiology of cerebral palsy. Semin Fetal Neonatal Med 11 (2006) 117-125
10. Paneth N., Hong T., and Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol 33 (2006) 251
11. Keogh J.M., and Badawi N. The origins of cerebral palsy. Curr Opin Neurol 19 (2006) 129-134
12. Nelson K.B. The epidemiology of cerebral palsy interm infants. Mental Retard Dev Dis Res Rev 8 (2002) 146-150
13. O'Shea T.M. Cerebral palsy in very preterm infants: new epidemiological insights. Mental Retard Dev Dis Res Rev 8 (2002) 135-145
14. Kurland L.T. Definitions of cerebral palsy and their role in epidemiologic research. Neurology (1956) 641-654
15. Nelson K.B., and Ellenberg J.H. Epidemiology of cerebral palsy. Adv Neurol 19 (1978) 421-435
16. Morris C. Definition and classification of cerebral palsy: a historical perspective. Dev Med Child Neurol 49 (2007) 3-7
17. Shankaran S., Laptook A.R., Ehrenkranz R.A., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 (2005) 1574-1584
18. Hirtz D. Classification of cerebral palsy: collaborative study perspective. Dev Med Child Neurol 49 (2007) 23
19. Blair E., Badawi N., and Watson L. Definition and classification of the cerebral palsies: the Australian view. Dev Med Child Neurol 49 (2007) 33-34
20. Paneth N., Qin H., Rosenbaum P., et al. Reliability of classification of cerebral palsy in low-birthweight children in four countries. Dev Med Child Neurol 45 (2003) 628-633
21. Scholtes V.A.B., Becher J.G., Beelen A., et al. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments. Dev Med Child Neurol 48 (2006) 64-73
22. Rosenbaum P.L., Walter S.D., Hanna S.E., et al. Prognosis or gross motor function in cerebral palsy: creation of motor development curves. J Am Med Assoc 288 (2002) 1357-1363
23. Beckung E., and Hagberg G. Correlation between ICIDH handicap code and Gross Motor Function Classification System in children with cerebral palsy. Dev Med Child Neurol 42 (2000) 669-673
24. Morris C., Galuppi B.E., and Rosenbaum P.L. Reliability of family report for the gross motor function classification system. Dev Med Child Neurol 46 (2004) 455-460
25. Jahnsen R., Aamodt G., and Rosenbaum P. Gross Motor Function Classification System used in adults with cerebral palsy: agreement of self-reported versus professional rating. Dev Med Child Neurol 48 (2006) 734-738
26. Palisano R.J., Cameron D., Rosenbaum P.L., et al. Stability of the gross motor function classification system. Dev Med Child Neurol 48 (2006) 424-428
27. McCormick A., Brien M., Plourde J., et al. Stability of the Gross Motor Function Classification System in adults with cerebral palsy. Dev Med Child Neurol 49 (2007) 265-269
28. Arnould C., Penta M., Renders A., et al. ABILHAND-Kids: a measure of manual ability in children with cerebral palsy. Neurology 63 (2004) 1045-1052
29. Beckung E., and Hagberg G. Neuroimpairments, activity limitations, and participation restrictions in children with cerebral palsy. Dev Med Child Neurol 44 (2002) 309-316
30. Eliasson A.C., Krumlinde-Sundholm L., Rosblad B., et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol 48 (2006) 549-554
31. Morris C., Kurinczuk J.J., Fitzpatrick R., et al. Reliability of the Manual Ability Classification System for children with cerebral palsy. Dev Med Child Neurol 48 (2006) 950-953
32. Damiano D., Abel M., Romness M., et al. Comparing functional profiles of children with hemiplegic and diplegic cerebral palsy in GMFCS Levels I and II: are separate classifications needed?. Dev Med Child Neurol 48 (2006) 797-803
33. Cans C. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Dev Med Child Neurol 42 (2000) 816-824
34. Blair E., and Stanley F. Issues in the classification and epidemiology of cerebral palsy. Mental Retard Dev Dis Res Rev 3 (1997) 184-193
35. O'Shea T.M. Definition and classification of cerebral palsy: an epidemiologist perspective. Dev Med Child Neurol 49 (2007) 29-30
36. Blair E., and Stanley F. Interobserver agreement in the classification of cerebral palsy. Dev Med Child Neurol 27 (1985) 615-622
37. Evans P., Johnson A., Mutch L., et al. A standard form for recording clinical findings in children with a motor deficit of central origin. Dev Med Child Neurol 31 (1989) 119-120
38. Love S. Better description of spastic cerebral palsy for reliable classification. Dev Med Child Neurol 49 (2007) 24-25
39. Hagberg B., Hagberg G., Olow I., et al. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr 85 (1996) 954-960
40. Krageloh-Mann I., Hagberg G., Meisner C., et al. Bilateral spastic cerebral palsy: a comparative study between south-west Germany and western Sweden. I. Clinical patterns and disabilities. Dev Med Child Neurol 35 (1993) 1037-1047
41. Doyle L.W. Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades. I. Effectiveness. Pediatrics 113 (2004) 505-509
42. Watt J.M., Robertson C.M.T., and Grace M.G.A. Early prognosis for ambulation on neonatal intensive care survivors with cerebral palsy. Dev Med Child Neurol 31 (1989) 766-773
43. Trahan J., and Marcoux S. Factors associated with the inability of children with cerebral-palsy to walk at 6 years: a retrospective study. Dev Med Child Neurol 36 (1994) 787-795
44. Sala D.A., and Grant A.D. Prognosis for ambulation in cerebral palsy. Dev Med Child Neurol 37 (1995) 1020
45. Ghidini A., Salafia C.M., and Minior V.K. Repeated courses of steroids in preterm membrane rupture do not increase the risk of histologic chorioamnionitis. Am J Perinatol 14 (1997) 309-313
46. Wu Y.W., Day S.M., Strauss D.J., et al. Prognosis for ambulation in cerebral palsy: a population-based study. Pediatrics 114 (2004) 1264-1271
47. O'Grady R.S., Crain L.S., and Kohn J. The prediction of long-term functional outcomes of children with cerebral palsy. Dev Med Child Neurol 37 (1995) 997-1005
48. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 41 (1995) 1403-1409
49. Dickinson H.O., Parkinson K.N., Ravens-Sieberer U., et al. Self-reported quality of life of 8-12-year-old children with cerebral palsy: a cross-sectional European study. Lancet 369 (2007) 2171-2178
50. Rosenbaum P.L., Livingston M.H., Palisano R.J., et al. Quality of life and health-related quality of life of adolescents with cerebral palsy. Dev Med Child Neurol 49 (2007) 516-521
51. Varni J.W., Burwinkle T.M., Berrin S.J., et al. The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the Generic Core Scales and Cerebral Palsy Module. Dev Med Child Neurol 48 (2006) 442-449
52. Vargus-Adams J. Health-related quality of life in childhood cerebral palsy. Arch Phys Med Rehabil 86 (2005) 940-945
53. Blair E. Life expectancy among people with cerebral palsy in Western Australia. Dev Med Child Neurol 43 (2001) 792
54. Hemming K., Hutton J.L., Colver A., et al. Regional variation in survival of people with cerebral palsy in the United Kingdom. Pediatrics 116 (2005) 1383-1390
55. Strauss D., Shavelle R., Reynolds R., et al. Survival in cerebral palsy in the last 20 years: signs of improvement?. Dev Med Child Neurol 49 (2007) 86-92
56. Graham E.M., Petersen S.M., Christo D.K., et al. Intrapartum electronic fetal heart rate monitoring and the prevention of perinatal brain injury. Obstet Gynecol 108 (2006) 656-666
57. Kiely J.L., Paneth N., Stein Z., et al. Cerebral palsy and newborn care. I. Secular trends in cerebral palsy. Dev Med Child Neurol 23 (1981) 533-538
58. Bhushan V., Paneth N., and Kiely J.L. Impact of improved survival of very low birth weight infants on recent secular trends in the prevalence of cerebral palsy. [see comments]. Pediatrics 91 (1993) 1094-1100
59. Pharoah P.O., Cooke T., Johnson M.A., et al. Epidemiology of cerebral palsy in England and Scotland, 1984-9. [see comments]. Arch Dis Child Fetal Neonatal Ed 79 (1998) F21-F25
60. Colver A.F., Gibson M., Hey E.N., et al. Increasing rates of cerebral palsy across the severity spectrum in north-east England 1964-1993. The North of England Collaborative Cerebral Palsy Survey. Arch Dis Child Fetal Neonatal Ed 83 (2000) F7-F12
61. Kavcic A., and Perat M.V. Prevalence of cerebral palsy in Slovenia: birth years 1981 to 1990. Dev Med Child Neurol 40 (1998) 459-463
62. Grether J.K., and Nelson K.B. Possible decrease in prevalence of cerebral palsy in premature infants?. J Pediatr 136 (2000) 133
63. Topp M., Uldall P., and Langhoff-Roos J. Trend in cerebral palsy birth prevalence in eastern Denmark: birth-year period 1979-86. Paediatr Perinat Epidemiol 11 (1997) 451-460
64. Cooke R.W.I. Trends in incidence of cranial ultrasound lesions and cerebral palsy in very low birthweight infants 1982-93. Arch Dis Child 80 (1999) F115-F117
65. O'Shea T.M., Preisser J.S., Klinepeter K.L., et al. Trends in mortality and cerebral palsy in a geographically based cohort of very low birth weight neonates born between 1982 to 1994. Pediatrics 101 (1998) 642-647
66. Robertson C.M.T., Watt M.J., and Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. J Am Med Assoc 297 (2007) 2733-2740
67. Vaucher Y.E., Harker L., Merritt T.A., et al. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. J Pediatr 122 (1993) 126-132
68. Walther F.J., Mullet M., Schumacher R., et al. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. J Pediatr 126 (1995) S13-S19
69. O'Shea T.M., and Doyle L.W. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol 6 (2001) 293-307
70. Paneth N. Classifying brain damage in preterm infants. J Pediatr 134 (1999) 527-529
71. Holling E.E., and Leviton A. Characteristics of cranial ultrasound white-matter echolucencies that predict disability: a review. Dev Med Child Neurol 41 (1999) 136-139
72. Stewart A.L., Reynolds E.O.R., Hope P.L., et al. Probability of neurodevelopmental disorders estimated from ultrasound appearance of brains of very preterm infants. Dev Med Child Neurol 29 (1987) 3-11
73. Dammann O., and Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42 (1997) 1-8
74. Collins M.P., Lorenz J.M., Jetton J.R., et al. Hypocapnia and other ventilation-related risk factors for cerebral palsy in low birth weight infants. Pediatr Res 50 (2001) 712-719
75. Dammann O., Allred E.N., Kuban K.C.K., et al. Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns ≤28 weeks gestation. Pediatr Res 49 (2001) 388-393
76. Dammann O., and Leviton A. Brain damage in preterm newborns: might enhancement of developmentally-regulated endogenous protection open a door for prevention?. Pediatrics 104 (1999) 541-550
77. Ment L.R., Oh W., Ehrenkranz R.A., et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 93 (1994) 543-550
78. Lucas A., and Cole T.J. Breast-milk and neonatal necrotizing enterocolitis. Lancet 336 (1990) 1519-1523
79. Crowley P.A. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 173 (1995) 322-335
80. Crowther C.A., Hiller J.E., Doyle L.W., et al. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. J Am Med Assoc 290 (2003) 2669-2676
81. Reuss M.L., Paneth N., Pinto-Martin J., et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 334 (1996) 821-827
82. Paneth N. Does transient hypothyroxinemia cause abnormal neurodevelopment in premature infants?. Clin Perinatol 25 (1998) 627-643
83. Ehrenkranz R.A., Walsh M.C., Vohr B.R., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116 (2005) 1353-1360
84. Schmidt B., Roberts R.S., Davis P., et al. Caffeine therapy for apnea of prematurity. N Engl J Med 354 (2006) 2112-2121
85. Van Marter L.J. Progress in discovery and evaluation of treatments to prevent bronchopulmonary dysplasia. Biol Neonate 89 (2006) 303-312
86. Schmidt B., Roberts R.S., Davis P., et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357 (2007) 1893-1902
87. Ambalavanan N., Tyson J.E., Kennedy K.A., et al. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics 115 (2005) E249-E254
88. Accardo P.J. Freud on diplegia: commentary and translation. Am J Dis Child 136 (1982) 452-456
89. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis the missing link?. Dev Med Child Neurol 35 (1993) 553-558
90. Adinolfi M. Infectious diseases in pregnancy. Cytokines and neurological impairment: an hypothesis. Dev Med Child Neurol 35 (1993) 549-553